Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study

By afschroeder • March 31, 2026

Marston NA, Bergmark BA, Prohaska TA, Moura FA, Zimerman A, Alexander VJ, Kang YM, Weinland J, Ran X, Murphy SA, Zhang S, Li D, Banach M, Stroes ESG, Kiss R, Gaudet D, Vrablik M, Goudev A, Bax JJ, Budoff MJ, Foldyna B, Lu MT, Tsimikas S, Giugliano RP, Sabatine MS. Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study. Circulation. 2026 Mar 30. doi: 10.1161/CIRCULATIONAHA.126.080012. Epub ahead of print. PMID: 41910513.

Tags: Cardiology/Epi, Harbor UCLA, Publications

A randomized controlled trial of pulsed field ablation vs antiarrhythmic therapy as a first-line treatment for persistent atrial fibrillation: The AVANT GUARD trial rationale and design

Wazni OM, Chun KJ, Amin A, Anic A, Ajijola OA, Gibson DN, Mansour M, Makati K, Chrispin J, Duytschaever M, Nair DG, Piccini JP, Natale[...]

Cardiac Myxoma With Atypical Presentation Leading to Delayed Diagnosis: A Case Report

Alishala M, Trinh T, Lee JS. Cardiac Myxoma With Atypical Presentation Leading to Delayed Diagnosis: A Case Report. Cureus. 2026 Feb 26;18(2):e104308. doi: 10.7759/cureus.104308. PMID:[...]

Cardiogenic Shock From Chronic Immune Checkpoint Inhibitor Associated Myocarditis Causing Predominant Right Ventricular Failure

Sekhon H, Rajendran PS, Hampilos K, Raddatz MA, Lilley CM, Zinoviev RI, Tai W, Stein-Merlob AF, Fishbein GA, Yang EH. Cardiogenic Shock From Chronic Immune[...]